HC Wainwright restated their buy rating on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note released on Friday morning, Benzinga reports. The firm currently has a $6.00 price objective on the stock. A number of other brokerages have also weighed in on SYRS. JMP Securities dropped their price objective on Syros […]

HC Wainwright reissued their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $55.00 price objective on the stock. Several other research firms have also weighed in on BCYC. Oppenheimer restated an “outperform” rating and issued a $48.00 target price on […]

HC Wainwright reiterated their buy rating on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $22.00 price target on the stock. A number of other equities research analysts have also issued reports on WVE. B. Riley increased their […]

Rosenblatt Securities reissued their buy rating on shares of Synaptics (NASDAQ:SYNA – Free Report) in a report released on Thursday, Benzinga reports. Rosenblatt Securities currently has a $130.00 price target on the software maker’s stock. A number of other brokerages have also weighed in on SYNA. JPMorgan Chase & Co. decreased their price objective on […]